PNU-100440
CAS No. 168828-82-8
PNU-100440( PNU100440 | PNU 100440 )
Catalog No. M27116 CAS No. 168828-82-8
PNU-100440 is a chemical compound.
PNU-100440 is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
|
10MG | 68 | In Stock |
|
25MG | 115 | In Stock |
|
50MG | 173 | In Stock |
|
100MG | 258 | In Stock |
|
200MG | 388 | In Stock |
|
500MG | 642 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePNU-100440
-
NoteResearch use only, not for human use.
-
Brief DescriptionPNU-100440 is a chemical compound.
-
DescriptionPNU-100440 is a chemical compound.
-
In Vitro——
-
In Vivo——
-
SynonymsPNU100440 | PNU 100440
-
PathwayOthers
-
TargetOther Targets
-
RecptorFatty acid desaturase Δ5D| Fatty acid desaturase Δ6D
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number168828-82-8
-
Formula Weight296.3
-
Molecular FormulaC14H17FN2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC[C@H]1CN(C2=CC=C(N3CCOCC3)C(F)=C2)C(O1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Simón MV, et al. Synthesis of docosahexaenoic acid from eicosapentaenoic acid in retina neurons protects photoreceptors from oxidative stress. J Neurochem. 2016 Mar;136(5):931-46.
molnova catalog
related products
-
DADLE
Prototypical δ-opioid receptor agonist that also displays activity at the μ-opioid receptor. Displays antinociceptive activity in vivo.
-
MID-1
MID-1 is an inhibitor of MG53-IRS-1 (Mitsugumin 53-Insulin Receptor Substrate-1) interaction.?It disrupts molecular association of MG53 with IRS-1 and abolishes MG53-induced IRS-1 ubiquitination and degradation in skeletal muscle, leading to elevated IRS-1 expression level and increased insulin signaling and glucose uptake.
-
Elamipretide 2TFA
Elamipretide is a novel mitochondrion-targeted antioxidant.?Treatment with elamipretide significantly ameliorated LPS-induced learning and memory impairment during behavioral tests.